Tuesday, April 12, 2022 9:27:38 AM
RE: Riverheaddaddy Post# 164092
Tuesday, April 12, 2022 7:53:47 AM
Post#
164094
of 164095
I also know for a fact, in all my years of trading these stupid pinkies (someday I will get out) most of the "Institutions" that fund/will fund companies do in fact look at history and will not buy into a company that has RS.
When a company does a RS, it is usually a signal that there has been some past wrong doings, financial hardship (regardless if current management is doing right)
In fact, in the paperwork to uplist, there are questions if the company had performed a RS and I believe that there is a period that they cannot uplist after a RS. It may be 1 year, but i'm not positive.
I do know a company cannot RS, then apply to uplist right away.
So it wouldn't help them in the short run to RS. Although I think it would need to be done to get this SS under control. A buyback is FAR more expensive than a RS. And regardless what any OTC company says, they DO NOT have the shareholders in best interest. That is the world of OTC.
I found this post in the wrong room...it fits here, right?
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM